1. EYA2 Correlates With Clinico-Pathological Features of Breast Cancer, Promotes Tumor Proliferation, and Predicts Poor Survival
   Hanxiao Xu et al, 2019, Frontiers in Oncology CrossRef
2. A case of metastatic colon cancer with RAS wild tumor progressed during the treatment with mFOLFOX6 plus panitumumab
   Kazuhiko Yoshimatsu et al, 2019, Annals of Cancer Research and Therapy CrossRef
3. Cytochrome P450 2U1 Is a Novel Independent Prognostic Biomarker in Breast Cancer Patients
   Bin Luo et al, 2020, Frontiers in Oncology CrossRef
4. Ion Channel Targeting with Antibodies and Antibody Fragments for Cancer Diagnosis
   Claudia Duranti et al, 2019, Antibodies CrossRef